Northwestern University
Clinical trials sponsored by Northwestern University, explained in plain language.
-
New hope for brittle bones after spinal cord injury: monthly shots show promise
Disease control CompletedThis study tested whether a monthly injection called romosozumab can improve bone health in women with chronic spinal cord injury and osteoporosis. Twelve women received the injections for one year, followed by a year of weekly alendronate pills. The goal was to see if the treatm…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Can a phone app help teens quit weed? new study says maybe.
Disease control CompletedThis study tested a smartphone app called TECH designed to help court-involved teens reduce or quit marijuana. Sixty teens aged 14-18 who had used cannabis in the past year and had a smartphone participated. The app provided a private online community where teens could support ea…
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Higher dose injection tested for Tough-to-Treat schizophrenia
Disease control CompletedThis study tested whether a higher dose of a long-acting injectable antipsychotic medication works better than the standard dose for people with schizophrenia or schizoaffective disorder. It involved 160 participants whose symptoms weren't well-controlled on their current medicat…
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Disease control
Last updated Apr 08, 2026 12:01 UTC
-
Texts that heal: new study tests phone messages for young adults avoiding therapy
Symptom relief CompletedThis study tested an 8-week text messaging program for young adults aged 18-25 with depression or anxiety who were not interested in or couldn't access in-person therapy. Participants received personalized or standard text messages, or weekly links to mental health info. The goal…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 18, 2026 12:11 UTC
-
Can a smartphone app curb self-harm in young adults?
Symptom relief CompletedThis study tested a digital mental health app for young adults (ages 18-25) who self-injure and are not in therapy. 90 participants were split into three groups: a self-guided app, the app with coaching, or an active control with educational content. The goal was to see if the ap…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 18, 2026 12:09 UTC
-
Personalized texts show promise in easing depression symptoms
Symptom relief CompletedThis study tested whether daily text messages that adapt to a person's preferences can help reduce depression symptoms. 100 adults with moderate to severe depression received either personalized messages, standard messages, or just educational links for 8 weeks. The goal was to s…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Brain training at home shows promise for Cancer-Related 'Chemo Brain'
Symptom relief CompletedThis study tested a home-based brain training program for 60 women who had finished chemotherapy for gynecologic cancers (like ovarian or uterine cancer) and were experiencing memory or thinking problems. Participants used a computer program called BrainHQ for 10 weeks. The goal …
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 12, 2026 13:41 UTC
-
New tech tool aims to ease depression in new and expecting moms
Symptom relief CompletedThis study tested a technology service to help care managers in obstetrics clinics better treat depression in pregnant women and new mothers. 75 English-speaking adults with moderate to severe depression who owned a smartphone took part. The goal was to see if the tech support im…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 11, 2026 20:49 UTC
-
Metformin may boost walking ability in PAD patients, trial finds
Symptom relief CompletedThis study tested whether taking metformin daily for six months helps people with peripheral artery disease (PAD) walk farther in six minutes. About 200 adults with PAD took either metformin or a placebo. The main goal was to see if metformin improves walking performance, which c…
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 11, 2026 20:37 UTC
-
Can a wearable device track your social life? new study explores
Knowledge-focused CompletedThis study tested whether wireless, wearable sensors can measure social interaction in healthy adults. 120 participants wore the sensors during daily activities to track how much they talked. Researchers also used a loneliness questionnaire to compare sensor data with self-report…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC